Please login to the form below

Not currently logged in
Email:
Password:

Jeff Jonker joins Theravance

He has experience at Genentech
Theravance Jeff Jonker

Theravance has appointed Jeff Jonker as senior VP, corporate and business development.

He joins the US-based biopharma from Satori where he served as chief business officer.

In his new role, he will report to Theravance CEO Rick Winningham and will hold responsibility for managing the company's business and corporate development affairs.

Prior to joining Satori, Jonker held senior roles at Genentech and Gloucester Pharmaceuticals.

"Jeff brings a wealth of industry and deal experience to Theravance,” said Winningham.

The CEO also commented that Jonkers' appointment will support the companys' plans to split into two biotech groups as its deals with GlaxoSmithKline are advanced.

“As Theravance separates into two companies, Jeff's track record of building successful companies and establishing strong collaborations will be important to our future growth,” said Winningham.

4th November 2013

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...
The era of digital wellbeing
Social media - friend or foe?...

Infographics